Skip to content

Clinical trials

Leukemia, Myelomonocytic, Chronic trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelomonocytic, Chronic Country / region: Japan Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20131
20141
20172
20191
20201
20211
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
AbbVie1
Astex Pharmaceuticals, Inc.1
Boehringer Ingelheim1
Celgene Corporation1
Pfizer1
Servier Bio-Innovation LLC1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelomonocytic, Chronic10
Myelodysplastic Syndromes9
Leukemia, Myeloid, Acute5
Hematologic Neoplasms1
Hodgkin Disease1
Lymphoma, Non-Hodgkin1
Multiple Myeloma1
Myeloproliferative Disorders1
Neoplasms1
Polycythemia Vera1

Trials

Showing 51 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.